aluates Reports

$ 0.0

Automative

Global HIV and AIDS Vaccine Market Research Report 2026

Published Date: 2026-03-16

Report Code: QYRE-Auto-17L17658

Global HIV and AIDS Vaccine Market Research Report 2024

BUY CHAPTERS

Global HIV and AIDS Vaccine Market Research Report 2026

Code: QYRE-Auto-17L17658

Report

2026-03-16

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson and Johnson (Janssen)

Sanofi Pasteur

Uvax Bio

IAVI

AELIX Therapeutics

HKUMed

HIV and AIDS Vaccine Market

The global HIV and AIDS Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on HIV and AIDS Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

The North American market for HIV and AIDS Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for HIV and AIDS Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of HIV and AIDS Vaccine include Johnson and Johnson (Janssen), Sanofi-Pasteur, Uvax Bio, AELIX Therapeutics, IAVI, HKUMed, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global HIV and AIDS Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding HIV and AIDS Vaccine. The HIV and AIDS Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global HIV and AIDS Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist HIV and AIDS Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of HIV and AIDS Vaccine Market Report

Report Metric	Details
Report Name	HIV and AIDS Vaccine Market
Segment by Type	Preventive Vaccine Therapeutic Vaccine
by Application	Viral Vector Vaccines Recombinant Protein Vaccines Nucleic Acid Vaccines (including mRNA Vaccines) Other Vaccines
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson and Johnson (Janssen), Sanofi-Pasteur, Uvax Bio, AELIX Therapeutics, IAVI, HKUMed
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for HIV and AIDS Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines HIV and AIDS Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the HIV and AIDS Vaccine Market report?

Ans: The main players in the HIV and AIDS Vaccine Market are Johnson and Johnson (Janssen), Sanofi-Pasteur, Uvax Bio, AELIX Therapeutics, IAVI, HKUMed

What are the Application segmentation covered in the HIV and AIDS Vaccine Market report?

Ans: The Applications covered in the HIV and AIDS Vaccine Market report are Viral Vector Vaccines, Recombinant Protein Vaccines, Nucleic Acid Vaccines (including mRNA Vaccines), Other Vaccines

What are the Type segmentation covered in the HIV and AIDS Vaccine Market report?

Ans: The Types covered in the HIV and AIDS Vaccine Market report are Preventive Vaccine, Therapeutic Vaccine

1 HIV and AIDS Vaccine Market Overview

1.1 Product Definition

1.2 HIV and AIDS Vaccine by Type

1.2.1 Global HIV and AIDS Vaccine Market Value by Type: 2025 vs 2032

1.2.2 Preventive Vaccine

1.2.3 Therapeutic Vaccine

1.3 HIV and AIDS Vaccine by Application

1.3.1 Global HIV and AIDS Vaccine Market Value by Application: 2025 vs 2032

1.3.2 Viral Vector Vaccines

1.3.3 Recombinant Protein Vaccines

1.3.4 Nucleic Acid Vaccines (including mRNA Vaccines)

1.3.5 Other Vaccines

1.4 Global HIV and AIDS Vaccine Market Size Estimates and Forecasts

1.4.1 Global HIV and AIDS Vaccine Revenue 2021–2032

1.4.2 Global HIV and AIDS Vaccine Sales 2021–2032

1.4.3 Global HIV and AIDS Vaccine Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 HIV and AIDS Vaccine Market Competition by Manufacturers

2.1 Global HIV and AIDS Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global HIV and AIDS Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global HIV and AIDS Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of HIV and AIDS Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of HIV and AIDS Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of HIV and AIDS Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of HIV and AIDS Vaccine, Date of Entry into the Industry

2.8 Global HIV and AIDS Vaccine Market Competitive Situation and Trends

2.8.1 Global HIV and AIDS Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global HIV and AIDS Vaccine Players Market Share by Revenue

2.8.3 Global HIV and AIDS Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global HIV and AIDS Vaccine Market Scenario by Region

3.1 Global HIV and AIDS Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global HIV and AIDS Vaccine Sales by Region: 2021–2032

3.2.1 Global HIV and AIDS Vaccine Sales by Region: 2021–2026

3.2.2 Global HIV and AIDS Vaccine Sales by Region: 2027–2032

3.3 Global HIV and AIDS Vaccine Revenue by Region: 2021–2032

3.3.1 Global HIV and AIDS Vaccine Revenue by Region: 2021–2026

3.3.2 Global HIV and AIDS Vaccine Revenue by Region: 2027–2032

3.4 North America HIV and AIDS Vaccine Market Facts & Figures by Country

3.4.1 North America HIV and AIDS Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America HIV and AIDS Vaccine Sales by Country (2021–2032)

3.4.3 North America HIV and AIDS Vaccine Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe HIV and AIDS Vaccine Market Facts & Figures by Country

3.5.1 Europe HIV and AIDS Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe HIV and AIDS Vaccine Sales by Country (2021–2032)

3.5.3 Europe HIV and AIDS Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific HIV and AIDS Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific HIV and AIDS Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific HIV and AIDS Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific HIV and AIDS Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America HIV and AIDS Vaccine Market Facts & Figures by Country

3.7.1 Latin America HIV and AIDS Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America HIV and AIDS Vaccine Sales by Country (2021–2032)

3.7.3 Latin America HIV and AIDS Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa HIV and AIDS Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa HIV and AIDS Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa HIV and AIDS Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa HIV and AIDS Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global HIV and AIDS Vaccine Sales by Type (2021–2032)

4.1.1 Global HIV and AIDS Vaccine Sales by Type (2021–2026)

4.1.2 Global HIV and AIDS Vaccine Sales by Type (2027–2032)

4.1.3 Global HIV and AIDS Vaccine Sales Market Share by Type (2021–2032)

4.2 Global HIV and AIDS Vaccine Revenue by Type (2021–2032)

4.2.1 Global HIV and AIDS Vaccine Revenue by Type (2021–2026)

4.2.2 Global HIV and AIDS Vaccine Revenue by Type (2027–2032)

4.2.3 Global HIV and AIDS Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global HIV and AIDS Vaccine Price by Type (2021–2032)

5 Segment by Application

5.1 Global HIV and AIDS Vaccine Sales by Application (2021–2032)

5.1.1 Global HIV and AIDS Vaccine Sales by Application (2021–2026)

5.1.2 Global HIV and AIDS Vaccine Sales by Application (2027–2032)

5.1.3 Global HIV and AIDS Vaccine Sales Market Share by Application (2021–2032)

5.2 Global HIV and AIDS Vaccine Revenue by Application (2021–2032)

5.2.1 Global HIV and AIDS Vaccine Revenue by Application (2021–2026)

5.2.2 Global HIV and AIDS Vaccine Revenue by Application (2027–2032)

5.2.3 Global HIV and AIDS Vaccine Revenue Market Share by Application (2021–2032)

5.3 Global HIV and AIDS Vaccine Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Johnson and Johnson (Janssen)

6.1.1 Johnson and Johnson (Janssen) Company Information

6.1.2 Johnson and Johnson (Janssen) Description and Business Overview

6.1.3 Johnson and Johnson (Janssen) HIV and AIDS Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Johnson and Johnson (Janssen) HIV and AIDS Vaccine Product Portfolio

6.1.5 Johnson and Johnson (Janssen) Recent Developments/Updates

6.2 Sanofi-Pasteur

6.2.1 Sanofi-Pasteur Company Information

6.2.2 Sanofi-Pasteur Description and Business Overview

6.2.3 Sanofi-Pasteur HIV and AIDS Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Sanofi-Pasteur HIV and AIDS Vaccine Product Portfolio

6.2.5 Sanofi-Pasteur Recent Developments/Updates

6.3 Uvax Bio

6.3.1 Uvax Bio Company Information

6.3.2 Uvax Bio Description and Business Overview

6.3.3 Uvax Bio HIV and AIDS Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Uvax Bio HIV and AIDS Vaccine Product Portfolio

6.3.5 Uvax Bio Recent Developments/Updates

6.4 AELIX Therapeutics

6.4.1 AELIX Therapeutics Company Information

6.4.2 AELIX Therapeutics Description and Business Overview

6.4.3 AELIX Therapeutics HIV and AIDS Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 AELIX Therapeutics HIV and AIDS Vaccine Product Portfolio

6.4.5 AELIX Therapeutics Recent Developments/Updates

6.5 IAVI

6.5.1 IAVI Company Information

6.5.2 IAVI Description and Business Overview

6.5.3 IAVI HIV and AIDS Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 IAVI HIV and AIDS Vaccine Product Portfolio

6.5.5 IAVI Recent Developments/Updates

6.6 HKUMed

6.6.1 HKUMed Company Information

6.6.2 HKUMed Description and Business Overview

6.6.3 HKUMed HIV and AIDS Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 HKUMed HIV and AIDS Vaccine Product Portfolio

6.6.5 HKUMed Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 HIV and AIDS Vaccine Industry Chain Analysis

7.2 HIV and AIDS Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 HIV and AIDS Vaccine Production Mode & Process Analysis

7.4 HIV and AIDS Vaccine Sales and Marketing

7.4.1 HIV and AIDS Vaccine Sales Channels

7.4.2 HIV and AIDS Vaccine Distributors

7.5 HIV and AIDS Vaccine Customer Analysis

8 HIV and AIDS Vaccine Market Dynamics

8.1 HIV and AIDS Vaccine Industry Trends

8.2 HIV and AIDS Vaccine Market Drivers

8.3 HIV and AIDS Vaccine Market Challenges

8.4 HIV and AIDS Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Johnson and Johnson (Janssen)

Sanofi Pasteur

Uvax Bio

IAVI

AELIX Therapeutics

HKUMed

List of Tables

Table 1. Global HIV and AIDS Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global HIV and AIDS Vaccine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global HIV and AIDS Vaccine Market Competitive Situation by Manufacturers in 2025

Table 4. Global HIV and AIDS Vaccine Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global HIV and AIDS Vaccine Sales Market Share by Manufacturers (2021–2026)

Table 6. Global HIV and AIDS Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global HIV and AIDS Vaccine Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market HIV and AIDS Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of HIV and AIDS Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of HIV and AIDS Vaccine, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of HIV and AIDS Vaccine, Product Types and Applications

Table 12. Global Key Manufacturers of HIV and AIDS Vaccine, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global HIV and AIDS Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on HIV and AIDS Vaccine Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global HIV and AIDS Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global HIV and AIDS Vaccine Sales by Region (K Units), 2021–2026

Table 18. Global HIV and AIDS Vaccine Sales Market Share by Region (2021–2026)

Table 19. Global HIV and AIDS Vaccine Sales by Region (K Units), 2027–2032

Table 20. Global HIV and AIDS Vaccine Sales Market Share by Region (2027–2032)

Table 21. Global HIV and AIDS Vaccine Revenue by Region (US$ Million), 2021–2026

Table 22. Global HIV and AIDS Vaccine Revenue Market Share by Region (2021–2026)

Table 23. Global HIV and AIDS Vaccine Revenue by Region (US$ Million), 2027–2032

Table 24. Global HIV and AIDS Vaccine Revenue Market Share by Region (2027–2032)

Table 25. North America HIV and AIDS Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America HIV and AIDS Vaccine Sales by Country (K Units), 2021–2026

Table 27. North America HIV and AIDS Vaccine Sales by Country (K Units), 2027–2032

Table 28. North America HIV and AIDS Vaccine Revenue by Country (US$ Million), 2021–2026

Table 29. North America HIV and AIDS Vaccine Revenue by Country (US$ Million), 2027–2032

Table 30. Europe HIV and AIDS Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe HIV and AIDS Vaccine Sales by Country (K Units), 2021–2026

Table 32. Europe HIV and AIDS Vaccine Sales by Country (K Units), 2027–2032

Table 33. Europe HIV and AIDS Vaccine Revenue by Country (US$ Million), 2021–2026

Table 34. Europe HIV and AIDS Vaccine Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific HIV and AIDS Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific HIV and AIDS Vaccine Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific HIV and AIDS Vaccine Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific HIV and AIDS Vaccine Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific HIV and AIDS Vaccine Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America HIV and AIDS Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America HIV and AIDS Vaccine Sales by Country (K Units), 2021–2026

Table 42. Latin America HIV and AIDS Vaccine Sales by Country (K Units), 2027–2032

Table 43. Latin America HIV and AIDS Vaccine Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America HIV and AIDS Vaccine Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa HIV and AIDS Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa HIV and AIDS Vaccine Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa HIV and AIDS Vaccine Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa HIV and AIDS Vaccine Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa HIV and AIDS Vaccine Revenue by Country (US$ Million), 2027–2032

Table 50. Global HIV and AIDS Vaccine Sales (K Units) by Type (2021–2026)

Table 51. Global HIV and AIDS Vaccine Sales (K Units) by Type (2027–2032)

Table 52. Global HIV and AIDS Vaccine Sales Market Share by Type (2021–2026)

Table 53. Global HIV and AIDS Vaccine Sales Market Share by Type (2027–2032)

Table 54. Global HIV and AIDS Vaccine Revenue (US$ Million) by Type (2021–2026)

Table 55. Global HIV and AIDS Vaccine Revenue (US$ Million) by Type (2027–2032)

Table 56. Global HIV and AIDS Vaccine Revenue Market Share by Type (2021–2026)

Table 57. Global HIV and AIDS Vaccine Revenue Market Share by Type (2027–2032)

Table 58. Global HIV and AIDS Vaccine Price (US$/Unit) by Type (2021–2026)

Table 59. Global HIV and AIDS Vaccine Price (US$/Unit) by Type (2027–2032)

Table 60. Global HIV and AIDS Vaccine Sales (K Units) by Application (2021–2026)

Table 61. Global HIV and AIDS Vaccine Sales (K Units) by Application (2027–2032)

Table 62. Global HIV and AIDS Vaccine Sales Market Share by Application (2021–2026)

Table 63. Global HIV and AIDS Vaccine Sales Market Share by Application (2027–2032)

Table 64. Global HIV and AIDS Vaccine Revenue (US$ Million) by Application (2021–2026)

Table 65. Global HIV and AIDS Vaccine Revenue (US$ Million) by Application (2027–2032)

Table 66. Global HIV and AIDS Vaccine Revenue Market Share by Application (2021–2026)

Table 67. Global HIV and AIDS Vaccine Revenue Market Share by Application (2027–2032)

Table 68. Global HIV and AIDS Vaccine Price (US$/Unit) by Application (2021–2026)

Table 69. Global HIV and AIDS Vaccine Price (US$/Unit) by Application (2027–2032)

Table 70. Johnson and Johnson (Janssen) Company Information

Table 71. Johnson and Johnson (Janssen) Description and Business Overview

Table 72. Johnson and Johnson (Janssen) HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Johnson and Johnson (Janssen) HIV and AIDS Vaccine Product

Table 74. Johnson and Johnson (Janssen) Recent Developments/Updates

Table 75. Sanofi-Pasteur Company Information

Table 76. Sanofi-Pasteur Description and Business Overview

Table 77. Sanofi-Pasteur HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Sanofi-Pasteur HIV and AIDS Vaccine Product

Table 79. Sanofi-Pasteur Recent Developments/Updates

Table 80. Uvax Bio Company Information

Table 81. Uvax Bio Description and Business Overview

Table 82. Uvax Bio HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Uvax Bio HIV and AIDS Vaccine Product

Table 84. Uvax Bio Recent Developments/Updates

Table 85. AELIX Therapeutics Company Information

Table 86. AELIX Therapeutics Description and Business Overview

Table 87. AELIX Therapeutics HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. AELIX Therapeutics HIV and AIDS Vaccine Product

Table 89. AELIX Therapeutics Recent Developments/Updates

Table 90. IAVI Company Information

Table 91. IAVI Description and Business Overview

Table 92. IAVI HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. IAVI HIV and AIDS Vaccine Product

Table 94. IAVI Recent Developments/Updates

Table 95. HKUMed Company Information

Table 96. HKUMed Description and Business Overview

Table 97. HKUMed HIV and AIDS Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. HKUMed HIV and AIDS Vaccine Product

Table 99. HKUMed Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. HIV and AIDS Vaccine Distributors List

Table 103. HIV and AIDS Vaccine Customers List

Table 104. HIV and AIDS Vaccine Market Trends

Table 105. HIV and AIDS Vaccine Market Drivers

Table 106. HIV and AIDS Vaccine Market Challenges

Table 107. HIV and AIDS Vaccine Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of HIV and AIDS Vaccine

Figure 2. Global HIV and AIDS Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global HIV and AIDS Vaccine Market Share by Type: 2025 & 2032

Figure 4. Preventive Vaccine Product Picture

Figure 5. Therapeutic Vaccine Product Picture

Figure 6. Global HIV and AIDS Vaccine Market Value by Application (US$ Million), 2021–2032

Figure 7. Global HIV and AIDS Vaccine Market Share by Application: 2025 & 2032

Figure 8. Viral Vector Vaccines

Figure 9. Recombinant Protein Vaccines

Figure 10. Nucleic Acid Vaccines (including mRNA Vaccines)

Figure 11. Other Vaccines

Figure 12. Global HIV and AIDS Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global HIV and AIDS Vaccine Market Size (US$ Million), 2021–2032

Figure 14. Global HIV and AIDS Vaccine Sales (K Units), 2021–2032

Figure 15. Global HIV and AIDS Vaccine Average Price (US$/Unit), 2021–2032

Figure 16. HIV and AIDS Vaccine Report Years Considered

Figure 17. HIV and AIDS Vaccine Sales Share by Manufacturers in 2025

Figure 18. Global HIV and AIDS Vaccine Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global HIV and AIDS Vaccine Players: Market Share by Revenue in HIV and AIDS Vaccine in 2025

Figure 20. HIV and AIDS Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global HIV and AIDS Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America HIV and AIDS Vaccine Sales Market Share by Country (2021–2032)

Figure 23. North America HIV and AIDS Vaccine Revenue Market Share by Country (2021–2032)

Figure 24. United States HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe HIV and AIDS Vaccine Sales Market Share by Country (2021–2032)

Figure 27. Europe HIV and AIDS Vaccine Revenue Market Share by Country (2021–2032)

Figure 28. Germany HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific HIV and AIDS Vaccine Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific HIV and AIDS Vaccine Revenue Market Share by Region (2021–2032)

Figure 35. China HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Southeast Asia HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America HIV and AIDS Vaccine Sales Market Share by Country (2021–2032)

Figure 43. Latin America HIV and AIDS Vaccine Revenue Market Share by Country (2021–2032)

Figure 44. Mexico HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Colombia HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa HIV and AIDS Vaccine Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa HIV and AIDS Vaccine Revenue Market Share by Country (2021–2032)

Figure 50. Turkey HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE HIV and AIDS Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of HIV and AIDS Vaccine by Type (2021–2032)

Figure 54. Global Revenue Market Share of HIV and AIDS Vaccine by Type (2021–2032)

Figure 55. Global HIV and AIDS Vaccine Price (US$/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of HIV and AIDS Vaccine by Application (2021–2032)

Figure 57. Global Revenue Market Share of HIV and AIDS Vaccine by Application (2021–2032)

Figure 58. Global HIV and AIDS Vaccine Price (US$/Unit) by Application (2021–2032)

Figure 59. HIV and AIDS Vaccine Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HIV and AIDS Clinical Trials Market Research Report 2025

Global Adult Vaccines Market Research Report 2024

Global HIV Clinical Trials Market Research Report 2025

Global HIV Prevention Drug Market Research Report 2024

Global Multiple Vaccine Market Research Report 2024

Global Vaccines for the Elderly Market Research Report 2024

Global Viral Arthritis Vaccine Market Research Report 2025

Global Human Immunodeficiency Virus Type 1 Market Research Report 2024

Global Artificial Intelligence AI in HIV and AIDS Market Research Report 2024

Global Vaccines For Cattle And Sheep Market Research Report 2024

Global Biopharmaceutical and Vaccines Market Research Report 2024

Global Monkeypox Virus Vaccine Market Research Report 2024

Global Harvest Aids Market Research Report 2025

Global Adult and Pediatric Vaccines Market Research Report 2024

Global Anti AIDs Drug Market Insights Forecast to 2030

Human Vaccine Adjuvants Market

Global Seasonal Vaccines Market Research Report 2024

Global HIV 1 Screening Tests Market Research Report 2025

Global Health Product for Immune Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions